Evotec SE Share Price Deutsche Boerse AG
Stocks
EVT
DE0005664809
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.090 EUR | -1.17% |
|
+5.34% | -6.78% |
| 06-30 | Evotec Expands Prefabricated Drug Manufacturing Offerings | MT |
| 06-30 | Just ? Evotec Biologics Launches J.TRAIN Turnkey Continuous Manufacturing Platform For Biologics | CI |
| Market Cap | 914M 1.05B 840M 783M 1.48B 99.51B 1.51B 10.08B 3.92B 48.91B 3.92B 3.84B 169B | P/E 2026 * |
-7.23x | P/E 2027 * | -26.3x |
|---|---|---|---|---|---|
| Enterprise Value | 928M 1.06B 853M 795M 1.51B 101B 1.53B 10.24B 3.98B 49.68B 3.98B 3.9B 171B | EV / Sales 2026 * |
1.26x | EV / Sales 2027 * | 1.2x |
| Free-Float |
89.91% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Evotec SE
| 1 day | -1.17% | ||
| 1 week | +5.34% | ||
| Current month | +1.09% | ||
| 1 month | +3.04% | ||
| 3 months | +14.36% | ||
| 6 months | -7.99% | ||
| Current year | -6.78% |
| 1 week | 4.88 |  | 5.2 |
| 1 month | 4.53 | | 5.2 |
| Current year | 4.02 | | 6.66 |
| 1 year | 4.02 | | 7.8 |
| 3 years | 4.02 | | 24.45 |
| 5 years | 4.02 | | 45.7 |
| 10 years | 3.66 | | 45.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 30/06/2024 | |
| Director of Finance/CFO | - | 30/04/2026 | |
Ingrid Müller
COO | Chief Operating Officer | - | 30/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Roland Sackers
BRD | Director/Board Member | 58 | 18/06/2019 |
| Director/Board Member | 64 | 31/05/2021 | |
| Director/Board Member | 43 | 21/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.17% | +5.34% | - | - | 1.05B | |
| +1.70% | +7.41% | +3.12% | +8.46% | 49.92B | |
| +0.92% | +3.93% | +399.71% | +605.33% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.35% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +64.58% | 33.09B | |
| +3.96% | +10.67% | +11.89% | +38.86% | 27.51B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +2.58% | +5.79% | +73.44% | +133.27% | 15.92B | |
| +0.32% | +0.58% | +13.67% | +19.09% | 13.86B | |
| +3.30% | +0.76% | +90.23% | +99.12% | 13.52B | |
| Average | +1.84% | +5.82% | +79.92% | +120.30% | 27.3B | |
| Weighted average by Cap. | +2.05% | +6.53% | +90.75% | +137.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 738M 844M 678M 632M 1.2B 80.34B 1.22B 8.14B 3.16B 39.49B 3.17B 3.1B 136B | 818M 936M 752M 701M 1.33B 89.07B 1.35B 9.02B 3.51B 43.78B 3.51B 3.44B 151B |
| Net income | -113M -130M -104M -96.99M -184M -12.33B -187M -1.25B -486M -6.06B -486M -476M -20.89B | -30.42M -34.8M -27.96M -26.06M -49.43M -3.31B -50.18M -336M -130M -1.63B -131M -128M -5.61B |
| Net Debt | 14.3M 16.36M 13.14M 12.25M 23.23M 1.56B 23.59M 158M 61.33M 766M 61.4M 60.08M 2.64B | 69.32M 79.3M 63.71M 59.38M 113M 7.55B 114M 765M 297M 3.71B 298M 291M 12.79B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/26 | €5.090 | -1.17% | 1,756 |
| 02/07/26 | €5.150 | -0.87% | 1,140 |
| 01/07/26 | €5.195 | +3.18% | 100 |
| 30/06/26 | €5.035 | +2.09% | 1,000 |
| 29/06/26 | €4.932 | +2.07% | 350 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EVT Stock
- EVT Stock
Select your edition
All financial news and data tailored to specific country editions
